2 recruiting, 1 active not recruiting. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Active not recruiting 1 |
Follow PharmaBio Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of PAL-222 Targeting Patients With Refractory Skin Ulcer Transplant surgery - Refractory Skin Ulcer | Not applicable | Recruiting | PharmaBio Corporation | 6 | 2025-04-15 | 2025-06-11 |
| Progression Suppression and Retinal Regression in VEGF-resistant AMD Pars plana vitrectomy - Neovascular Age-related Macular Degeneration (AMD) | Not applicable | Recruiting | PharmaBio Corporation | 10 | 2024-09-12 | 2026-09-18 |
| Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA) Pars plana vitrectomy - Myopic Chorioretinal Atrophy | Not applicable | Active not recruiting | PharmaBio Corporation | 10 | 2023-02-17 | 2026-09-29 |
Skin Ulcer (1)
Japan (3)